Free fatty acids inhibit the glucose-stimulated increase of intramuscular glucose-6-phosphate concentration in humans

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 5, 2001, Pages 2153-2160

  Krebs, Michael ^a   Krssak, Martin ^a   Nowotny, Peter ^a   Weghuber, Daniel ^a   Gruber, Stephan ^b   Mlynarik, Vladimir ^b   Bischof, Martin ^a   Stingl, Harald ^a   Fürnsinn, Clemens ^a   Waldhäusl, Werner ^a   Roden, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; CREATINE PHOSPHATE; FATTY ACID; GLUCOSE; GLUCOSE 6 PHOSPHATE; INSULIN; LIPID; PHOSPHATE; SOMATOSTATIN;

ADULT; ARTICLE; CONTROLLED STUDY; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; HUMAN EXPERIMENT; LIPID ANALYSIS; MALE; MUSCLE METABOLISM; NORMAL HUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; SKELETAL MUSCLE;

ADULT; BLOOD GLUCOSE; FATTY ACIDS, NONESTERIFIED; GLUCOSE; GLUCOSE-6-PHOSPHATE; HUMANS; INSULIN; MALE; MUSCLE, SKELETAL; PHOSPHATES;

EID: 17744383753     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.5.2153     Document Type: Article

References (55)

1. 1H NMR spectroscopy study. Diabetologia. 42:113-116.
2. Perseghin G, Ghosh S, Gerow K, Shulman GI. 1997 Metabolic defects in lean nondiabetic offspring of NIDDM parents. Diabetes. 46:1001-1009.
3. Boden G. 1996 Role of fatty acids in the pathogenesis of insulin resistance and IDDM. Diabetes. 45:3-10.
4. Reaven GM. 1988 Role of insulin resistance in human disease. Diabetes. 37:1595-1607.
5. Boden G, Chen X, Ruiz J, White JV, Rossetti L. 1994 Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest. 93:2438-2446.
6. Boden G, Jadali F. 1991 Effects of lipid on basal carbohydrate metabolism in normal men. Diabetes. 40:686-692.
7. Dresner A, Laurent D, Marcucci M, et al. 1999 Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest. 103:253-259.
8. Lee KU, Lee HK, Koh CS, Min HK. 1988 Artificial induction of intravascular lipolysis by lipid-heparin infusion leads to insulin resistance in man. Diabetologia. 31:285-290.
9. Roden M, Krssak M, Stingl H, et al. 1999 Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans. Diabetes. 48:358-364.
10. Roden M, Price TB, Perseghin G, et al. 1996 Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest. 97:2859-2865.
11. Saloranta C, Koivisto V, Widen E, et al. 1993 Contribution of muscle and liver to glucose-fatty acid cycle in humans. Am J Physiol. 264:E599-E605.
12. Vaag A, Handberg A, Skott P, Damsbo P, Richter EA, Beck-Nielsen H. 1994 Glucose-fatty acid cycle operates in humans at the level of both whole body and skeletal muscle during low and high physiological plasma insulin concentrations. Eur J Endocrinol. 130:70-79.
13. Randle PJ, Garland PB, Newsholme EA, Hales CN. 1965 The glucose fatty acids cycle in obesity and maturity onset diabetes mellitus. Ann NY Acad Sci. 131:324-333.
14. Randle PJ, Hales CN, Garland PB, Newsholme EA. 1963 The glucose fatty- acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. I:785-789.
15. Kim JK, Wi JK, Youn JH. 1996 Plasma free fatty acids decrease insulin- stimulated skeletal muscle glucose uptake by suppressing glycolysis in conscious rats. Diabetes. 45:446-453.
16. Jucker BM, Rennings AJM, Cline GW, Shulman GI. 1997 In vivo NMR investigation of intramuscular glucose metabolism in conscious rats. J Biol Chem. 272:10464-10473.
17. Chalkley SM, Hettiarachi M, Chrisholm DJ, Kraegen EW. 1998 Five-hour fatty acid elevation increases muscle lipids and impairs glycogen synthesis. Metabolism. 47:1121-1126.
18. Koyama K, Chen G, Lee Y, Unger RH. 1997 Tissue triglycerides, insulin resistance, and insulin production: implication for hyperinsulinemia of obesity. Am J Physiol. 273:E708-E713.
19. Pan DA, Lillioja S, Kriketos AD, et al. 1997 Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes. 46:983-988.
20. 1H spectroscopy: validation in vivo. Am J Physiol. 276:E977-E989.
21. Roden M, Perseghin G, Petersen KF, et al. 1996 The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans. J Clin Invest. 97:642-648.
22. Gerich JE, Lorenzi M, Bier M, et al. 1976 Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. J Clin Invest. 57:875-884.
23. Hother-Nielsen O, Vaag A, Skott P, Beck-Nielsen H. 1993 Effect of hyperglycemia per se on glucose turnover rates in patients with insulin-dependent diabetes. Metabolism. 42:86-93.
24. 31P-nuclear magnetic resonance spectroscopy. Neurology. 35:781-788.
25. 31P-Nuclear magnetic resonance measurements of muscle glucose-6-phosphate: evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in noninsulin-dependent diabetes mellitus. J Clin Invest. 89:1069-1075.
26. 2+ on the Keq of the creating kinase reaction and other phosphate hydrolyses and phosphate transfer reactions. J Biol Chem. 254:6528-6537.
27. Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hanicke W, Sauter R. 1989 Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo. Magn Reson Med. 9:79-93.
28. Boesch C, Slotboom J, Hoppeler H, Kreis R. 1997 In vivo determination of intra-myocellular lipids in human muscle by means of localized H-1-MR-spectroscopy. Magn Reson Med. 37:484-493.
29. 13C-labeling pattern of glucose by gas chromatography-mass spectrometry. Anal Chem. 212:526-531.
30. Mandarino LJ, Consoli A, Jain A, Kelley DE. 1993 Differential regulation of intracellular glucose metabolism by glucose and insulin in human muscle. Am J Physiol. 265:E898-E905.
31. Inzucchi SE, Maggs MD, Spollett GR, et al. 1998 Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. N Engl J Med. 338:867-872.
32. Carlson MG, Snead WL, Campbell PJ. 1993 Regulation of free fatty acid metabolism by glucagon. J Clin Endorinol Metab. 77:11-15.
33. Schade DS, Eaton RP. 1975 Modulation of fatty acid metabolism by glucagon in man. Diabetes. 24:502-509.
34. Yoo-Warren H, Willse AG, Hancock N, Hull J, McCaleb M, Livingston JN. 1994 Regulation of rat glucagon receptor expression. Biochim Biophys Res Commun. 205:347-353.
35. Zierler K. 1999 Whole body glucose metabolism. Am J Physiol. 276:E409-E426.
36. Laurent D, Falk Petersen K, Russell RR, Cline GW, Shulman GI. 1998 Effect of epinephrine on muscle glycogenolysis and insulin-stimulated muscle glycogen synthesis in humans. Am J Physiol. 274:E130-E138.
37. Johnson AB, Argyraki M, Thow JC, Cooper BG, Fulcher G, Taylor R. 1992 Effect of increased free fatty acid supply on glucose metabolism and skeletal muscle glycogen synthase activity in normal man. Clin Sci. 82:219-226.
38. Hargreaves M, Kiens B, Richter EA. 1991 Effect of increased plasma free fatty acid concentrations on muscle metabolism during exercise in men. J Appl Physiol. 70:194-201.
39. Rossetti L, Giaccari A. 1990 Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake. A dose-response euglycemic clamp study in normal and diabetic rats. J Clin Invest. 85:1785-1792.
40. Baron AD, Brechtel G, Wallace P, Edelman SV. 1988 Rates and tissue sites of noninsulin- and insulin-mediated glucose uptake in humans. Am J Physiol. 255:E769-E774.
41. Liljenquist JE, Mueller GL, Cherrington AD, Perry JM, Rabinowitz D. 1979 Hyperglycemia per se (insulin and glucagon withdrawn) can inhibit hepatic glucose production in man. J Clin Endorinol Metab. 48:171-175.
42. Sacca L, Hendler R, Sherwin RS. 1978 Hyperglycemia inhibits glucose production in man independent of changes in glucoregulatory hormones. J Clin Endorinol Metab. 47:1160-1163.
43. Katz A, Raz I, Spencer K, Rising R, Mott DM. 1991 Hyperglycemia induces accumulation of glucose in human skeletal muscle. Am J Physiol. 260:R698-R703.
44. Borkman M, Storlien LH, Pan DA, Jenkins AB, Chrisholm DJ, Campbell LV. 1993 The relation between insulin sensitivity and the fatty-acid composition of skeletal muscle phospholipids. N Engl J Med. 328:238-244.
45. Clore JN, Li J, Gill R, et al. 1998 Skeletal muscle phosphatidylcholine fatty acids and insulin sensitivity in normal humans. Am J Physiol. 275:E665-E670.
46. 2. J Biol Chem. 271:1138-1144.
47. Shepherd PR, Kahn BB. 1999 Implications for insulin resistance and diabetes mellitus. N Engl J Med. 341:248-257.
48. Hawkins M, Barzilai N, Liu R, Hu M, Chen W, Rosetti L. 1997 Role of the glucosamine pathway in fat-induced insulin resistance. J Clin Invest. 99:2173-2182.
49. Griffin ME, Marcucci MJ, Cline GW, et al. 1999 Free fatty acid-induced insulin resistance is associated with activation of protein kinase C θ and alterations in the insulin signaling cascade. Diabetes. 48:1270-1274.
50. Kinoshita Y, Fukase M, Nakai M, Fujita T. 1996 Arachidonic acid inhibits phosphate transport by cultured renal cells. Biochem Biophys Res Commun. 143:991-996.
51. Bonadonna RC, Groop LC, Zych K, Shank M, DeFronzo RA. 1990 Dose-dependent effect of insulin on plasma free fatty acid turnover and oxidation in humans. Am J Physiol. 259:E736-E750.
52. Sidossis LS, Wolfe RR. 1996 Glucose and insulin-induced inhibition of fatty acid oxidation: the glucose fatty acid cycle reversed. Am J Physiol. 270:E733-E738.
53. Bonadonna RC, Zych K, Boni C, Ferrannini E, DeFronzo RA. 1989 Time dependence of the interaction between lipid and glucose in humans. Am J Physiol, 257:E49-E56.
54. Yki-Järvinen H, Puhakainen I, Koivisto VA. 1991 Effect of free fatty acids on glucose uptake and nonoxidative glycolysis across human forearm tissues in the basal state and during insulin stimulation. J Clin Endocrinol Metab. 72:1268-1277.
55. Krebs M, Stingl H, Nowotny P, et al. 2000 Prevention of in vitro lipolysis by tetrahydrolipstatin. Clin Chem. 46:950-954